Adenosine

Product NDC: 0409-1932
11-digit product format: 004091932
Labeler code: 0409
Product ID: 0409-1932_af4ef593-85c4-472a-9d07-5cd821e25715
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ADENOSINE
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: Hospira, Inc.
Application: ANDA203883
Marketing category: ANDA
Marketing start: 2014-04-02
Marketing end: 0000-00-00
Substance: ADENOSINE
Active strength: 3 mg/mL
Pharmacologic classes: Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0409-1932		D	Discontinued by firm	2026-08-10
excluded package	package	0409-1932	0409-1932-01	D	Discontinued by firm	2026-08-10
excluded package	package	0409-1932	0409-1932-02	D	Discontinued by firm	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0409-1932-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0409-1932-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0409-1932-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0409-1932-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0409-1932-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0409-1932-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0409-1932-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0409-1932-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0409-1932-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0409-1932-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0409-1932-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0409-1932-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0409-1932-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0409-1932-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0409-1932-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0409-1932-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0409-1932-02	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0409-1932-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0409-1932-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0409-1932-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0409-1932-02	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0409-1932-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0409-1932-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0409-1932-01	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A203883-001	ADENOSINE	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS			2014-03-24
A203883-002	ADENOSINE	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS			2014-03-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS		2014-03-24	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203883-001	ADENOSINE	60MG/20ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A203883-002	ADENOSINE	90MG/30ML (3MG/ML)	SOLUTION / INTRAVENOUS	AP	2014-03-24	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 50 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203883-001	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203883-002	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203883-001	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A203883-002	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203883-001	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A203883-002	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203883-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203883-002	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203883-001	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A203883-002	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203883-001	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A203883-002	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A203883-001	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A203883-002	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A203883-001	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A203883-002	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A203883-001	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A203883-002	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A203883-001	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A203883-002	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A203883-001	AP	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A203883-002	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A203883-001	AP	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A203883-002	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A203883-001	AP	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A203883-002	AP	1	`ea99ee380514…`
2024-02-18 07:12 UTC	2024-02	A203883-001	AP	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A203883-002	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A203883-001	AP	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A203883-002	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A203883-001	AP	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A203883-002	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A203883-001	AP	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A203883-002	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A203883-001	AP	1	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A203883-002	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A203883-001	AP	1	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A203883-002	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A203883-001	AP	1	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	A203883-002	AP	1	`053a50430f4f…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d676a241-be05-4740-b3ee-1a5f2ed422d2	Product name	4	20180615
dd8bd48f-20d6-43c7-b471-3ae872868afa	Product name	3	20180125
d41954ff-bc63-4b2c-aba0-9146707659d7	Product name	2	20151117

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0409-1932-01	ML - Milliliter	0409-1932	89bc78a0-1374-4b4e-bb70-884b70b20a60	1	2014-05-02
0409-1932-02	ML - Milliliter	0409-1932	f7966a1c-56f8-4088-bd8e-e61f98bc0c0d	1	2014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ADENOSINE	ACTIVE INGREDIENT	K72T3FS567	ADENOSINE INJECTION, SOLUTION [HOSPIRA, INC.]	2
ADENOSINE	ACTIVE MOIETY	K72T3FS567	ADENOSINE INJECTION, SOLUTION [HOSPIRA, INC.]	2
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	ADENOSINE INJECTION, SOLUTION [HOSPIRA, INC.]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	ADENOSINE INJECTION, SOLUTION [HOSPIRA, INC.]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
K72T3FS567	ADENOSINE	58-61-7	ADENOSINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1654035	adenosine 60 MG in 20 mL Injection	PSN	7be465d5-f2d6-99db-e053-2991aa0a52f0	4
1654035	20 ML adenosine 3 MG/ML Injection	SCD	7be465d5-f2d6-99db-e053-2991aa0a52f0	4
1654035	adenosine 60 MG per 20 ML Injection	SY	7be465d5-f2d6-99db-e053-2991aa0a52f0	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0409-1932-01	00409193201	1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1932-01) > 20 mL in 1 VIAL, SINGLE-DOSE	2014-04-02	0000-00-00	No	No	Current
0409-1932-02	00409193202	1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1932-02) > 30 mL in 1 VIAL, SINGLE-DOSE	2014-04-02	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Adenosine	Hospira, Inc. \| Gland Pharma Limited	2024-01-29	HUMAN PRESCRIPTION DRUG LABEL	12
ADENOSINE INJECTION, USP 60mg/20mL (3mg/mL) 20mL VIAL	HF Acquisition Co LLC, DBA HealthFirst	2022-12-09	HUMAN PRESCRIPTION DRUG LABEL	4